RESÚMENES OCTUBRE 2010

Eutimizantes

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o estudio aleatorizado; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

3 - Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder

Article author query

kubota m [PubMed]  [Google Scholar]

kasahara t [PubMed]  [Google Scholar]

iwamoto k [PubMed]  [Google Scholar]

komori a [PubMed]  [Google Scholar]

ishiwata m [PubMed]  [Google Scholar]

miyauchi t [PubMed]  [Google Scholar]

kato t [PubMed]  [Google Scholar]

Mie Kubota, Takaoki Kasahara, Kazuya Iwamoto, Atsuko Komori, Mizuho Ishiwata, Taeko Miyauchi and Tadafumi Kato

The International Journal of Neuropsychopharmacology (2010), 13: 1355-1368

 

3 - Effect of fasting during Ramadan on serum lithium level and mental state in bipolar affective disorder

Farooq, Saeed

International Clinical Psychopharmacology: November 2010 - Volume 25 - Issue 6 - pp 323-327

 

5< - Antidepressants for the Acute Treatment of Bipolar Depression: A Systematic Review and Meta-Analysis

Michelle M. Sidor, and Glenda M. MacQueen,MD, PhD

J Clin Psychiatry. October 2010

 

3 - Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine




References and further reading may be available for this article. To view references and further reading you must
purchase this article.

Samira S. Valvassori, Gislaine T. Rezin, Camila L. Ferreira, Morgana Moretti, Cinara L. Gonçalves, Mariana R. Cardoso, Emílio L. Streck, Flávio Kapczinski and João Quevedo

Journal of Psychiatric Research. Volume 44, Issue 14, October 2010, Pages 903-909

 

3 - Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting




References and further reading may be available for this article. To view references and further reading you must
purchase this article.

Terence A. Ketter, John O. Brooks III, Jennifer C. Hoblyn, Anne A. Holland, Jennifer Y. Nam, Jenifer L. Culver, Wendy K. Marsh and Julie C. Bonner

Journal of Psychiatric Research. Volume 44, Issue 14, October 2010, Pages 921-929

 

3! - Meta-analysis of the effects of lithium usage on serum creatinine levels

R. Paul, J. Minay, C. Cardwell, D. Fogarty, C. Kelly

J Psychopharmacol October 2010 vol. 24 no. 10 1425-1431

 

3 - Lithium-induced suicidal erythrocyte death

JP Nicolay, S. Gatz, F. Lang, UE Lang

J Psychopharmacol October 2010 vol. 24 no. 10 1533-1539

 

3 - Hyperinsulinemia associated with overweight medicated bipolar patients during full remission

Kuo-Hsuan Chung, Shang-Ying Tsai

Psychiatry and Clinical Neurosciences. October 2010

 

 3 - Long-term effectiveness of aripiprazole in adolescents and young adults with bipolar disorder: A naturalistic study

Ching-Shu Tang, Chin-Bin Yeh, Yu-Shu Huang, Liang-Jen Wang, Wen-Jiun Chou, Miao-Chun Chou & Chih-Ken Chen

International Journal of Psychiatry in Clinical Practice. November 2010, Vol. 14, No. 4 , Pages 252-256

 

3 - Asenapine: A Review of Acute and Extension Phase Data in Bipolar Disorder

Roger S. McIntyre

CNS Neuroscience & Therapeutics. October 2010

 

3 - Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year “open” follow-up study

Giulio Perugi, Franco Frare, Cristina Toni, Giuseppe Tusini, Giulia Vannucchi and Hagop S. Akiskal

European Archives of Psychiatry and Clinical Neuroscience. Volume 260, Number 7, 553-560

 

3 - The role of genetic variation of BDNF gene in antidepressant-induced mania in bipolar disorder

Ferreira Ade A, Neves FS, Pimenta GJ, Mello MP, Miranda DM, Romano-Silva MA, De Marco LA, Corrêa H

Psychiatry Res. 2010 Nov 30;180(1):54-6

 

3! - Epidemiologic study of aripiprazole use and the incidence of suicide events

Marianne Ulcickas Yood, Gerald DeLorenze, Charles P. Quesenberry Jr, Ai-Lin Tsai, Syd Phillips, Vincent J. Willey, Steve J. Niemcryk, Karen Wells, Mary Lou Skovron, Mark J. Cziraky, William Carson, Susan A. Oliveria

Pharmacoepidemiology and Drug Safety. Volume 19, Issue 11, pages 1124–1130, November 2010

 

5< - Levetiracetam in the Management of Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

Aybala Saricicek, Kathleen Maloney, Anjana Muralidharan, Barbara Ruf, Hilary P. Blumberg, Gerard Sanacora, Boris Lorberg, Brian Pittman, and Zubin Bhagwagar

J Clin Psychiatry. October 2010

 

5< - Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

Joseph R. Calabrese, Terence A. Ketter, James M. Youakim, Jane M. Tiller, Ronghua Yang, and Mark A. Frye

J Clin Psychiatry 2010;71(10):1363–1370


3 - Risperidone long-acting injectable for maintenance treatment in patients with bipolar disorder

William V Bobo and Richard C Shelton

Expert Review of Neurotherapeutics. November 2010, Vol. 10, No. 11, Pages 1637-1658

 

3! - Comparison of Antidepressant Responses in Patients with Bipolar vs. Unipolar Depression: A Meta-Analytic Review

G. Vázquez, L. Tondo, R. J. Baldessarini

Pharmacopsychiatry. October 2010 


3 - Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targets

Nir Lipsman, Roger S McIntyre, Peter Giacobbe, Cristina Torres, Sidney H Kennedy, Andres M Lozano

Bipolar Disorders. Volume 12, Issue 7, pages 691–701, November 2010

 

3 - The pharmacogenetics of antidepressant-induced mania: a systematic review and meta-analysis

Federico M Daray, Sairah B Thommi, S Nassir Ghaemi

Bipolar Disorders. Volume 12, Issue 7, pages 702–706, November 2010

 

3! - Regulation of glycogen synthase kinase-3 during bipolar mania treatment

Xiaohong Li, Min Liu, Zhuoji Cai, Gang Wang, Xiaohua Li

Bipolar Disorders. Volume 12, Issue 7, pages 741–752, November 2010


 


Regresar a RESÚMENES OCTUBRE 2010


© 1999-2010 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA